Bristol-Myers' Planned Purchase of Celgene Gets 2019 Off to Hot M&A Start

The video discusses the Mega M&A landscape, focusing on the Bristol Myers and Celgene deal. It highlights market volatility, regulatory pressures, and potential acquisition targets in the healthcare sector. The discussion also covers the impact of political factors, such as Nancy Pelosi's stance on drug prices, and the role of private equity in healthcare M&A. The video concludes with an outlook on future trends, including the influence of technology and companies like Amazon.

Which companies are suggested as potential acquisition targets in the healthcare sector?

What role does private equity play in the healthcare technology space according to the text?